General Gynecology · Gynecologic Oncology

Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention

George SH, Garcia R, Slomovitz BM

Published May 21, 2016 Frontiers in Oncology, 6, 108
DOI 10.3389/fonc.2016.00108 PMID 27200296 PMC PMC4852190

Abstract

High-grade serous carcinoma (HGSC) is the most common and aggressive histotype of epithelial ovarian cancer (EOC), and it is the predominant histotype associated with hereditary breast and ovarian cancer syndrome (HBOC). Mutations in BRCA1 and BRCA2 are responsible for most of the known causes of HBOC, while mutations in mismatch repair genes and several genes of moderate penetrance are responsible for the remaining known hereditary risk. Women with a history of familial ovarian cancer or with known germline mutations in highly penetrant genes are offered the option of risk-reducing surgery that involves the removal of the ovaries and fallopian tubes (salpingo-oophorectomy). Growing evidence now supports the fallopian tube epithelia as an etiological site for the development of HGSC and consequently, salpingectomy alone is emerging as a prophylactic option. This review discusses the site of origin of EOC, the rationale for risk-reducing salpingectomy in the high-risk population, and opportunities for salpingectomy in the low-risk population.

Topics

Related research

General Gynecology › Gynecologic Oncology › Ovarian Cancer · Reproductive Surgery › Tubal Surgery › Tubal Cannulation
Sophia H L George, Ruslan Garcia, Brian M Slomovitz
S George, R Garcia, B Slomovitz
PMID 27200296 27200296 DOI 10.3389/fonc.2016.00108 10.3389/fonc.2016.00108 George et al. 2016, George 2016